Ankle SprainTECARNCT06934629
Efficacy of Tecar Device With Exercises in Ankle Sprain
A study testing TECAR therapy and therapeutic exercises in people with Ankle Sprain and TECAR Therapy, run by Cairo University at 1 site in Egypt.
Trial summary
The goal of this clinical trial is to evaluate the effect of applying TECAR therapy during active therapeutic exercises on pain, ankle dynamic balance, proprioception, and daily function in patients with acute ankle sprain. Read more about this study
- Who is it for?
- Ages 20 to 40 years
- Conditions the study is for
- Ankle Sprain, TECAR Therapy, TECAR Therapy Efficacy in the Treatment of Ankle Sprain
- What is being tested?
- TECAR therapy and therapeutic exercises
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Dec 2024to 30 Jul 2025
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Gender will be male and female.
- Age from 20-40 years old.
- Grade | and || lateral ankle sprain.
- Patients who will be diagnosed and referred by orthopedic surgeon.
- acute stage of lateral ankle sprain.
- BMI ≤ 30.
- Positive confirming tests.
Who cannot join
- Ankle fractures such as talus bone fracture, tibia fracture, ankle dislocation.
- Unwilling to continue treatment.
- Contraindications to use TECAR therapy, such as pregnancy, the presence of malignant tissue, tumors, in the ankle, and electrical devices implanted in the body.
- Grade ||| ankle sprain.
- Systematic diseases such as rheumatoid arthritis.
- Recently received intra-steroid injection
- Pain exacerbation during the intervention.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Tecar Therapy During Active Exercises on Dynamic Balance in Acute Ankle Sprain
The goal of this clinical trial is to evaluate the effect of applying TECAR therapy during active therapeutic exercises on pain, ankle dynamic balance, proprioception, and daily function in patients with acute ankle sprain.
the main questions it aims to answer are:
Read more
- Does there is a significant effect of applying TECAR therapy during active exercise after acute lateral ankle sprain on Pain?
- Does there is a significant effect of applying TECAR therapy during active exercise after acute lateral ankle sprain on balance?
- Does there is a significant effect of applying TECAR therapy during active exercise after acute lateral ankle sprain on proprioception?
- Does there is a significant effect of applying TECAR therapy during active exercise after acute lateral ankle sprain on daily function? The patients will be randomly divided into two groups. The control group (A) will receive the conventional therapy which is ankle and subtalar ROM in a pain-free range, calf muscle stretch, ankle strengthening exercises against resistance bands in all directions, weight-bearing exercise, forward lunges, bilateral and unilateral squats, bilateral and unilateral heel raises against bodyweight resistance, and balance training. The experiment group (B) will receive conventional therapy with TECAR therapy application during active therapeutic exercises.
Treatment will be for 4 weeks with 2 sessions per week. TECAR application will be 20 mins per session (10 mins capacitive and 10 mins resistive).
To the best of the researchers' knowledge, no study has proved the effects of applying TECAR therapy during active therapeutic exercises after an acute lateral ankle sprain has yet been done. Thus, the purpose of the present study was to prove if there an effect of applying TECAR therapy during active therapeutic exercises included in the conventional physiotherapy (PRICE with therapeutic exercises) and conventional physiotherapy alone on pain, ankle dynamic balance, proprioception, and daily function in subjects with an acute lateral ankle sprain.
- Conditions
- Ankle Sprain, TECAR Therapy, TECAR Therapy Efficacy in the Treatment of Ankle Sprain, Ankle Dynamic Balance, Ankle Pain, Ankle Proprioception
- Being tested
- TECAR therapy, therapeutic exercises
- Keywords
- Ankle pain, ankle dynamic balance, Ankle proprioception, Ankle daily function, TECARtherapy
- Medical subject headings
- Ankle Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TECAR therapyDevice
TECAR application will be 20 mins per session (10 mins capacitive and 10 mins resistive) during ankle and subtalar ROM in a pain-free range, calf muscle stretch, ankle strengthening exercises against resistance bands in all directions, weight-bearing exercise, forward lunges, bilateral and unilateral squats, bilateral and unilateral heel raises against bodyweight resistance, and balance training.
therapeutic exercisesOther
the conventional therapy which is ankle and subtalar ROM in a pain-free range, calf muscle stretch, ankle strengthening exercises against resistance bands in all directions, weight-bearing exercise, forward lunges, bilateral and unilateral squats, bilateral and unilateral heel raises against bodyweight resistance, and balance training.
| Study group | Role | What they receive |
|---|---|---|
| TECAR therapy group | Experimental | traditional therapeutic exercises for ankle sprain and TECAR therapy application during exercises . Receives: Device: TECAR therapy |
| Conventional therapy group | Active comparator | traditional therapeutic exercises for ankle sprain Receives: Other: therapeutic exercises |
What is being measured
The primary outcome is the main question the study is designed to answer.
1.ankle dynamic balance.
using Y-Balance Test (YBT)
Measured: from enrollment to the end of treatment at 4 weeks.
2.pain
using Numerical pain rating scale (NPRS)
Measured: from enrollment to the end of treatment at 4 weeks.
Secondary outcomes (2)
3. proprioception
using digital inclinometer
Measured: from enrollment to the end of treatment at 4 weeks.
4. Daily Function
Using FAAM questionnaire
Measured: from enrollment to the end of treatment at 4 weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Apr 2025
- Study start15 Dec 2024
- Primary completion30 May 2025
- Study completion30 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Ankle SprainStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Model description
- Treatment will be for 4 weeks with 2 sessions per week. TECAR application will be 20 mins per session (10 mins capacitive and 10 mins resistive) during ankle and subtalar ROM in a pain-free range, calf muscle stretch, ankle strengthening exercises against resistance bands in all directions, weight-bearing exercise, forward lunges, bilateral and unilateral squats, bilateral and unilateral heel raises against bodyweight resistance, and balance training.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Asmaa Morsy Elsayed Ali Morsy, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06934629
- Sponsor's protocol ID
- P.T.REC/012/005596
- Acronym
- TECAR
- Status last verified
- Apr 2026
- First submitted
- 2 Apr 2025
- Last updated
- 15 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided